https://7acc2inhibitor.com/und....erstanding-of-modifi
The exterior credibility associated with the 2019 Briganti nomogram for estimating LNI threat was assessed via calibration, discrimination, and decision curve analyses (DCAs). A total of 38 (8%) patients had LNI at last pathology. The median wide range of nodes eliminated had been 18 (interquartile range 14-24). On exterior validation, the 2019 Briganti nomogram had an area underneath the receiver running characteristic curve (AUC) of 79%. Althoam predicting lymph node invasion specificall